Reaching the End of the Line: Urinary Tract Infections - PubMed
Review
Reaching the End of the Line: Urinary Tract Infections
Kevin O Tamadonfar et al. Microbiol Spectr. 2019 May.
Abstract
Urinary tract infections (UTIs) cause a substantial health care burden. UTIs (i) are most often caused by uropathogenic Escherichia coli (UPEC), (ii) primarily affect otherwise healthy females (50% of women will have a UTI), (iii) are associated with significant morbidity and economic impact, (iv) can become chronic, and (v) are highly recurrent. A history of UTI is a significant risk factor for a recurrent UTI (rUTI). In otherwise healthy women, an acute UTI leads to a 25 to 50% chance of rUTI within months of the initial infection. Interestingly, rUTIs are commonly caused by the same strain of E. coli that led to the initial infection, arguing that there exist host-associated reservoirs, like the gastrointestinal tract and underlying bladder tissue, that can seed rUTIs. Additionally, catheter-associated UTIs (CAUTI), caused by Enterococcus and Staphylococcus as well as UPEC, represent a major health care concern. The host's response of depositing fibrinogen at the site of infection has been found to be critical to establishing CAUTI. The Drug Resistance Index, an evaluation of antibiotic resistance, indicates that UTIs have become increasingly difficult to treat since the mid-2000s. Thus, UTIs are a "canary in the coal mine," warning of the possibility of a return to the preantibiotic era, where some common infections are untreatable with available antibiotics. Numerous alternative strategies for both the prevention and treatment of UTIs are being pursued, with a focus on the development of vaccines and small-molecule inhibitors targeting virulence factors, in the hopes of reducing the burden of urogenital tract infections in an antibiotic-sparing manner.
Figures

UPEC pathogenesis. (A) UPEC is housed in a reservoir in the gastrointestinal system. The bacteria are able to colonize the urinary tract from this reservoir. (B) Bacteria are able to adhere to and invade the bladder epithelial cells. (C) Bacterial cells can be evicted from the host cell in response. Bacterial cells can also enter the cytoplasm (D) and initiate IBC formation (E). (F) UPEC can, upon fluxing out of the host cells, filament and reinfect other urothelial cells. (G) To counteract intracellular pathogens, the host can initiate a program of host cell exfoliation. (H) Chronic cystitis in mice can occur with persistent high titers of bacteriuria. (I) QIRs can be established, in mice with resolved infections, in layers below superficial urothelial cells. Image and caption are adapted from reference .

Overview of UPEC fitness and virulence factors. Surface-associated structures that play a role in UTI pathogenesis include lipopolysaccharide, polysaccharide capsule, flagella, pili, toxins, secretion systems (SS), and siderophore receptors. Image and caption are adapted from reference .

Overview of CUP of pilus assembly and mode of action of antivirulence compounds. (A) Sec transports unfolded subunits of the pilus structure into the periplasmic space. (B, C, G, H) Pilus subunits interact with the pilus type-specific chaperone and fold. (D) Chaperone-subunit complexes interact with the N terminus of the pilus usher. (E) Secreted subunits, bound together through donor strand exchange, form the pilus. (F) Small-molecule inhibitors, mannosides and galactosides, antagonize interactions between the adhesive tip of the pilus and its ligand. Pilicides bind to the chaperone (I) and interrupt the interaction between chaperone and the N terminus of the usher (J). Image and caption are adapted from reference .
Similar articles
-
Guiton PS, Cusumano CK, Kline KA, Dodson KW, Han Z, Janetka JW, Henderson JP, Caparon MG, Hultgren SJ. Guiton PS, et al. Antimicrob Agents Chemother. 2012 Sep;56(9):4738-45. doi: 10.1128/AAC.00447-12. Epub 2012 Jun 25. Antimicrob Agents Chemother. 2012. PMID: 22733070 Free PMC article.
-
Sawant NV, Chang SS, Pandit KA, Khekare P, Warner WR, Zimmern PE, De Nisco NJ. Sawant NV, et al. Microbiol Spectr. 2024 Mar 5;12(3):e0271223. doi: 10.1128/spectrum.02712-23. Epub 2024 Jan 19. Microbiol Spectr. 2024. PMID: 38240572 Free PMC article.
-
Conover MS, Hadjifrangiskou M, Palermo JJ, Hibbing ME, Dodson KW, Hultgren SJ. Conover MS, et al. mBio. 2016 Apr 12;7(2):e00104-16. doi: 10.1128/mBio.00104-16. mBio. 2016. PMID: 27073089 Free PMC article.
-
Zhou Y, Zhou Z, Zheng L, Gong Z, Li Y, Jin Y, Huang Y, Chi M. Zhou Y, et al. Int J Mol Sci. 2023 Jun 23;24(13):10537. doi: 10.3390/ijms241310537. Int J Mol Sci. 2023. PMID: 37445714 Free PMC article. Review.
Cited by
-
Moxley RA, Bargar TW, Kachman SD, Baker DR, Francis DH. Moxley RA, et al. Microorganisms. 2020 Feb 15;8(2):263. doi: 10.3390/microorganisms8020263. Microorganisms. 2020. PMID: 32075320 Free PMC article.
-
Cranberry Polyphenols and Prevention against Urinary Tract Infections: Relevant Considerations.
González de Llano D, Moreno-Arribas MV, Bartolomé B. González de Llano D, et al. Molecules. 2020 Aug 1;25(15):3523. doi: 10.3390/molecules25153523. Molecules. 2020. PMID: 32752183 Free PMC article. Review.
-
Burgess SA, Moinet M, Brightwell G, Cookson AL. Burgess SA, et al. Microb Genom. 2022 Oct;8(10):mgen000893. doi: 10.1099/mgen.0.000893. Microb Genom. 2022. PMID: 36200854 Free PMC article.
-
Chorro L, Li Z, Chu L, Singh S, Gu J, Kim JH, Dutta K, Pan R, Kodali S, Ndreu D, Patel A, Hawkins JC, Ponce C, Silmon de Monerri N, Keeney D, Illenberger A, Jones CH, Andrew L, Lotvin J, Prasad AK, Kanevsky I, Jansen KU, Anderson AS, Donald RGK. Chorro L, et al. Infect Immun. 2022 Apr 21;90(4):e0002222. doi: 10.1128/iai.00022-22. Epub 2022 Mar 21. Infect Immun. 2022. PMID: 35311580 Free PMC article.
-
Notermans DW, Schoffelen AF, Landman F, Wielders CCH, Witteveen S, Ganesh VA, van Santen-Verheuvel M, de Greeff SC, Kuijper EJ, Hendrickx APA; Dutch CPE Surveillance Study Group. Notermans DW, et al. J Antimicrob Chemother. 2022 Oct 28;77(11):3205-3208. doi: 10.1093/jac/dkac307. J Antimicrob Chemother. 2022. PMID: 36171716 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical